Arthritis
318
28
39
178
Key Insights
Highlights
Success Rate
87% trial completion (above average)
Published Results
57 trials with published results (18%)
Research Maturity
178 completed trials (56% of total)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
8.5%
27 terminated out of 318 trials
86.8%
+0.3% vs benchmark
11%
36 trials in Phase 3/4
32%
57 of 178 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 178 completed trials
Clinical Trials (318)
Natural History and Development of Spondyloarthritis
A Safety and Efficacy Study of the Birmingham Hip Resurfacing System
Natural History, Genetics, and Pathophysiology of Systemic Juvenile Idiopathic Arthritis, Adult-Onset Still's Disease, and Related Conditions
Pain in Inflammatory Joint Diseases
A Qualitative Assessment of the Severity and Impact of Rheumatic Immune-Related Adverse Events Following Immune Checkpoint Inhibitor Immunotherapy
Studies of the Natural History of Rheumatic Diseases
Expanding Exercise Programming for Veterans Through Telehealth
Radiation to Treat Joint Damage Caused by Cancer Immunotherapy
SakuraBead Used as Resorbable Embolic for Genicular Artery Embolization
Study of Dapansutrile Tablets in Subjects With an Acute Gout Flare
Phone-Based Based Walk With Ease Program for Adults With Arthritis
Mechanisms of Action of Acetaminophen
Geniculate Artery Embolization for Osteoarthritis
Conjoint Analysis of Patient Preferences in Joint Interventions
The Sequestration of Holistic Stress Management Techniques for Adults
Multicenter Orthopaedic Outcomes Network (MOON) ACL Reconstruction (ACLR): 10 Year Onsite Follow-up
The Efficacy of Ultrasonication in Combination With Corticosteroid Intraarticular Injection for Arthritis
Methotrexate for Immune Related Arthritis or Arthralgias (IMPACT 2.1)
A Multi-center Outcomes Clinical Study of the PyroTITAN™ HRA Shoulder Implant in Humeral Head Resurfacing
Ultralow Dose PET Imaging for 18F-NaF Uptake